Whole genome sequencing for Klebsiella pneumoniae in the Tunisian antimicrobial resistance surveillance system: micro-costing, pragmatic cost-effectiveness, and budget impact evaluation
The Lancet Regional Health - Eastern Mediterranean · 2026-11 · 2 · 100005
DOI: 10.1016/j.laneme.2026.100005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Regional Health - Eastern Mediterranean, 2026-11. Verfasst von Dana Itani und 11 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Itani, D., Allel, K., Farjani, S., Smaoui, H., Zribi, M., Thabet, L., Achour, W., Baker, D. J., Moss, C., Foster-Nyarko, E., Holt, K., & Boubaker, I. B. (2026). Whole genome sequencing for Klebsiella pneumoniae in the Tunisian antimicrobial resistance surveillance system: micro-costing, pragmatic cost-effectiveness, and budget impact evaluation. The Lancet Regional Health - Eastern Mediterranean, 2, 100005. https://doi.org/10.1016/j.laneme.2026.100005
Vancouver
Itani D, Allel K, Farjani S, Smaoui H, Zribi M, Thabet L, et al. Whole genome sequencing for Klebsiella pneumoniae in the Tunisian antimicrobial resistance surveillance system: micro-costing, pragmatic cost-effectiveness, and budget impact evaluation. The Lancet Regional Health - Eastern Mediterranean. 2026;2:100005. doi:10.1016/j.laneme.2026.100005
BibTeX
@article{Itani2026,
author = {Itani, Dana and Allel, Kasim and Farjani, Sanaa and Smaoui, Hanen and Zribi, Meriam and Thabet, Lamia and Achour, Wafaa and Baker, Dave J and Moss, Cara-Jane and Foster-Nyarko, Ebenezer and Holt, Kathryn and Boubaker, Ilhem Boutiba-Ben},
title = {Whole genome sequencing for Klebsiella pneumoniae in the Tunisian antimicrobial resistance surveillance system: micro-costing, pragmatic cost-effectiveness, and budget impact evaluation},
journal = {The Lancet Regional Health - Eastern Mediterranean},
year = {2026},
volume = {2},
pages = {100005},
doi = {10.1016/j.laneme.2026.100005}
}
EUVIMED